Tardio Jason Insider Trades

Insider Trading History

Track insider trading activity for Tardio Jason. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Immunic
Immunic IMUX
President And COO
Holding Value $9.52M 660,000 shares
Last Trade
Jul 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$887k 990,000 shares
$0.90
$14.43
Immunic
Immunic IMUX
President And COO
Holding Value $8.59M 595,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$458k 595,000 shares
$0.77
$14.43
Immunic
Immunic IMUX
President And COO
Holding Value $181k 12,512 shares
Last Trade
Jun 05, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.88k 12,512 shares
$0.79
$14.43
Immunic
Immunic IMUX
President And COO
Holding Value $8.64M 598,500 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$461k 598,500 shares
$0.77
$14.43
Immunic
Immunic IMUX
President And COO
Holding Value $2.27M 157,500 shares
Last Trade
Dec 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$197k 157,500 shares
$1.25
$14.43
Immunic
Immunic IMUX
President And COO
Holding Value $7.22M 500,000 shares
Last Trade
Jul 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$625k 500,000 shares
$1.25
$14.43
Ovid Therapeutics
Ovid Therapeutics OVID
Chief Operating Officer
Holding Value $419k 168,750 shares
Last Trade
Feb 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$621k 168,750 shares
$3.68
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
Chief Operating Officer
Holding Value $434k 175,000 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$438k 175,000 shares
$2.50
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Sep 12, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$37.3k 17,344 shares
$2.15
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
Chief Operating Officer
Holding Value $217k 87,498 shares
Last Trade
Apr 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$314k 107,498 shares
$2.92
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
Chief Operating Officer
Holding Value $434k 175,000 shares
Last Trade
Feb 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$476k 175,000 shares
$2.72
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
Chief Commercial Officer
Holding Value $124k 50,000 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$198k 50,000 shares
$3.95
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
Chief Commercial Officer
Holding Value $186k 75,000 shares
Last Trade
Feb 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 75,000 shares
$3.19
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
Chief Commercial Officer
Holding Value $434k 175,000 shares
Last Trade
Dec 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$494k 175,000 shares
$2.82
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
Chief Commercial Officer
Holding Value $109k 44,000 shares
Last Trade
Nov 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264k 44,000 shares
$5.99
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
Chief Commercial Officer
Holding Value $124k 50,000 shares
Last Trade
Jun 19, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$370k 50,000 shares
$7.40
$2.48
Ovid Therapeutics
Ovid Therapeutics OVID
Chief Commercial Officer
Holding Value $310k 125,000 shares
Last Trade
Nov 18, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$345k 125,000 shares
$2.76
$2.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up